Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04776642

Biobank for "Arrhythmia and Conduction Disorders: TowArd Pathophysiology Based Treatment"

"Arrhythmia and Conduction Disorders: TowArd Pathophysiology Based Treatment" ADAPT Biobank

Status
Recruiting
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The 'ADAPT' Biobank is a collection of body material and data from patients with or at risk of cardiac arrhythmias who underwent or will undergo (non-) invasive treatment for this disease. Its main objective is to obtain a comprehensive collection of patient information and material to facilitate research and gain better insight into the complex pathophysiology of the different arrhythmias, the multifactorial process, the heterogeneity in clinical presentation, and prognosis. Bodily material is used for biochemical marker assessments, histological and molecular analyses for research in cardiac arrhythmias.

Detailed description

The pathophysiological process of many cardiac arrhythmias is complex because of its multifactorial character. Despite extensive research that has already been performed in the field of electrophysiology the exact pathophysiological process of the different arrhythmias remains incompletely understood. The ability to identify subgroups of patients within a population with the same type of arrhythmia that can benefit from a specific treatment strategy might provide more individualized therapeutic opportunities, improve prognostication or provide preventive opportunities in patient with cardiac arrhythmias. Biobanks can make a valuable contribution to the development of diagnostic, preventive and therapeutic methods. More insights into the correlations between genes, environmental factors and susceptibility to illness may be of great value. The 'ADAPT' Biobank has been designed to establish a systematic and qualitative collection of bodily materials for future research in the cardiovascular field. The Biobank includes bodily material of patients with cardiac arrhythmias undergoing (non-) invasive treatment or control patients undergoing cardiothoracic surgery. Clinical data related to the cardiac arrhythmic disease is recorded. The data and samples will be linked to the participants' medical records to allow longitudinal follow-up.

Conditions

Interventions

TypeNameDescription
OTHERBiobank for Left atrial appendage tissueBodily material is used for biochemical marker assessments, histological and molecular analyses for research in cardiac arrhythmias.
OTHERBiobank for BloodBodily material is used for biochemical marker assessments, histological and molecular analyses for research in cardiac arrhythmias.
OTHERBiobank for One or more of following fat patches: epicardial fat, subcutaneous fat, pericardial fat, visceral fat.Bodily material is used for biochemical marker assessments, histological and molecular analyses for research in cardiac arrhythmias.

Timeline

Start date
2014-12-18
Primary completion
2030-01-01
Completion
2030-01-01
First posted
2021-03-02
Last updated
2024-01-25

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT04776642. Inclusion in this directory is not an endorsement.